Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells

Journal of Urology

Volumn 163, Issue 3, 2000, Pages 985-992

  Davies, G ^a   Jiang, W G ^b   Mason, M D ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

Adhesion molecules; APC; Cell cell aggregation; GSK3 ; Invasion; Prostate cancer

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CATENIN; CD31 ANTIGEN; DESMOGLEIN; DESMOPLAKIN; UVOMORULIN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER MORTALITY; CELL ADHESION; CELL AGGREGATION; CYTOSKELETON; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0033951080     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67869-X     Document Type: Article

References (63)

1. Woolf, S. H.: Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med, 333: 1401, 1995
2. Boring, C. C., Squires, T. S. and Tong, T.: Cancer Statistics 1993. CA Cancer J Clin, 43: 7, 1993
3. Black, R. J., Bray, F., Ferlay, J. and Parkin, D. M.: Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer, 33: 1075, 1997
4. Smart, C. R.: The results of prostate carcinoma screening in the U. S. as reflected in the surveillance, epidemiology and end results program. Cancer, 80: 1835, 1997
5. Liotta, L. A. and Strack, M. L.: Tumour invasion and metastases: biochemical mechanisms. Cancer Treat Res, 40: 223, 1988
6. Hart, I. R., Goode, N. T. and Wilson, R. E.: Molecular aspects of the metastatic cascade. Biochem Biophys Acta, 989: 65, 1989
7. Tsukita, S., Tsukita, S. A., Nagafuchi, A. and Yonemura, S.: Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. Curr Opin Biol, 4: 834, 1992
8. Kemler, R.: From cadherins to catenins: cytoplasmic protein interaction and regulation of cell adhesion. TIG, 9: 317, 1993
9. Wheelock, M. J. and Knudsen, K. A.: Cadherins and associated proteins. In Vivo, 5: 505, 1991
10. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D. and Birchmeier, W.: E-cadherin mediated cell cell-adhesion prevents invasiveness of human carcinoma cells. J Cell Biol, 113: 173, 1991
11. Birchmeier, W., Weidner, K. M., Hulsken, J. and Behren, J.: Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Seminars in Cancer Biology, 4: 231, 1993
12. Mareel, M., Berx, G., Vanroy, F. and Bracke, M.: Cadherin/ catenin complex-a target for anti invasive therapy. J Cell Biochem, 61: 524, 1996
13. Bringuier, P. P., Umbas, R., Schaafsma, H. E., Karthaus, H. F. M., Debruyne, F. M. J. and Schalken, J. A.: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res, 53: 3241, 1993
14. Garrod, D. R.: Desmosomes and hemidesmosomes. Curr Opinion Cell Biol, 5: 30, 1993
15. Demlehner, M. P., Schafer, S., Grund, C. and Franke, W. W.: Continual assembly of half desmosomal structures in the absence of cell contacts and their frustrated endocytosis: a coordinated sisyphus cycle. J Cell Biol, 131: 745, 1995
16. Hiscox, S. and Jiang, W. G.: Expression of E-cadherin, α-, β- and γ-catenin in human colorectal cancer. Anticancer Res, 17: 1349, 1997
17. Hart, J. M., de los Santos, R., Albert, I. N., Rubinfeld, B. and Polakis, P. Downregulation of β-catenin by human axin and its association with the APC tumor suppressor, β-catenin and GSK3β. Current Biol, 8: 573, 1998
18. Hulsken, J., Birchmeier, W. and Behrens, J.: E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J Cell Biol., 127: 2061, 1994
19. Shibata, T., Gotoh, M., Ochiai, A. and Hirohashi, S.: Association of plakoglobin with APC, a tumour suppressor gene product and its regulation by tyrosine phosphorylation. Biochem Biophys Res Commun 203: 519, 1994
20. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S. and Polakis, P.: Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science, 272: 1023, 1996
21. Cox, R. T. and Peifer, M.: Wingless signalling: the inconvenient complexities of life. Current Biology, 8: R140, 1998
22. Huber, O., Korn, R., McLaughlin, J., Oshugi, M., Herrmann, B. G. and Kemler, R.: Nuclear localisation of β-catenin by interaction with transcription factor LEF-1. Mechan Dev, 59: 3, 1996
23. Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F. M., Schaafsma, H. E., Debruyne, F. M. J. and Isaacs, W. B.: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res, 52: 5104, 1992
24. Davies, G., Jiang, W. G. and Mason, M. D.: E-cadherin and associated molecules in the invasion and progression of prostate cancer. Oncology Reports, 5: 1567, 1998
25. Morton, R. A., Ewing, C. M., Nagafuchi, A., Tsukita, S. and Isaacs, W. B.: Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res, 53: 3585, 1993
26. Bussemakers, M. J. C., Van Moorselaar, R. J. A., Giroldi, L. A., Ichikawa, T., Isaacs, J. T., Debruyne, F. M. J. and Schalken, J. A.: Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res, 52: 2916, 1992
27. Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. J. G., Brooks, J. D. and Ewing, C. M.: Molecular genetics and chromosomal alterations in prostate cancer. Cancer Suppl, 75: 2004, 1995
28. Umbas, R., Isaac, W. B., Bringuier, D. P., Schaafsma, H. E., Karthaus, H. F., Oosterhof, G. O., Debruyne, F. M. and Schalken, J. A.: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer Cancer Res, 54: 3929, 1994
29. Ewing, C. M., Ru, K., Morton, R. A., Robinson, J. C., Wheelock, M. J., Johnson, K. R., Barrett, J. C. and Isaacs, W. B.: Chromosome 5 suppresses tumorigenicity of PC-3 prostate cancer cells: correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res, 55: 4813, 1995
30. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E. and Baylin, S. B.: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res, 55: 5195, 1995
31. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K. and Shimizu, S.: Molecular cloning and expression of human hepatocyte growth factor. Nature, 342: 440, 1989
32. Stoker, M. and Gherardi, E.: Regulation of cell movement. Biochem Biophys Acta, 1072: 81, 1991
33. Rosen, E., Meromsky, L., Setter, E., Vinter, D. W. and Goldberg, I. D.: Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis, 10: 49, 1990
34. Weidner, K. M., Behrens, J., Vandekerckhove, J. and Birchmeier, W.: Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol, 111: 2097, 1990
35. Jiang, W. G., Hiscox, S., Hallett, M. B., Scott, C., Horrobin, D. F. and Puntis, M. C. A.: Inhibition of hepatocyte growth factor/ scatter factor induced motility and invasion of human cancer cells by gamma linolenic acid. Br J Cancer, 71: 744, 1995
36. Jiang, W. G., Hiscox, S., Matsumoto, K. and Kakamura, T.: Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29: 209, 1999
37. Kuniyasu, H., Ellis, L. M., Evans, D. B., Abbruzzese, J. L., Fenoglio, C. J., Bucana, C. D., Cleary, K. R., Tahara, E. and Fidler, I. J.: Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res, 5: 25, 1999
38. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M. and McEwan, R. N.: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47: 3239, 1987
39. Takeichi, M.: Functional correlation between cell adhesive properties and some cell surface proteins. J Cell Biol, 75: 464, 1977
40. Vleminckx, K. L., Deman, J. J., Bruyneel, E. A., Vandenbossche, G. M. R., Keirsebilck, A. A., Mareel, M. and van Roy, F. M.: Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Cancer Res, 54: 873, 1994
41. Sokoloff, M. H., Tso, C-L., Kaboo, R., Taneja, S., Pang, S., Dekernion, J. B. and Belldegrun, A. S.: In vitro modulation of tumour progression associated properties of hormone refractory prostate carcinoma cell line by cytokines. Cancer, 77: 1862, 1996
42. Koch, P. J. and Franke, W. W.: Desmosomal cadherins, another growing multigene family of adhesion molecules. Curr Opinion Cell Biol, 6: 682, 1994
43. Takeichi, M.: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development, 102: 639, 1988
44. Takeichi, M.: Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251: 1451, 1991
45. Behrens, J., Mareel, M. M., Van, R. F. and Birchmeier, W.: Dissecting tumour cell invasion: epithelial cell acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol, 109: 2435, 1989
46. Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W. and Van Roy, F.: Genetic manipulations of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell, 66: 107, 1991
47. Richmond, P. J. M., Karayiannakis, A. J., Nagafuchi, A., Kaisary, A. V. and Pignatelli, M.: Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res, 57: 3189, 1997
48. Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayash, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., Takeichi, M. and Mori, T.: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res, 53: 1696, 1993
49. Miyata, M., Shiozaki, H., Iihara, K., Shimaya, K., Oka, H. and Kadowaki, T.: Relationship between E-cadherin expression and lymph node metastasis in human oesophageal cancer. Int J Oncol, 4: 61, 1994
50. Ozawa, M., Baribault, H. and Kemler, R.: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J, 8: 1711, 1990
51. Takeichi, M., Hirano, S., Matsuyoshi, N., and Fujimori, T.: Cytoplasmic control of cadherin-mediated cell-cell adhesion. Cold Spring Harbor Symp Quart Biol, 57: 327, 1992
52. Knudsen, K. A., Soler, A. P., Johnson, K. R. and Wheelock, M. J.: Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J Cell Biol, 130: 67, 1995
53. Shimoyama, Y., Nagafuchi, A., Fujita, S., Gotoh, M., Takeichi, M., Tsukita, S. and Hiorhashi, S.: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res, 52: 5770, 1992
54. 2+-dependent cell-cell adhesion. Cell Adhesion Commun, 1: 239, 1993
55. Birchmeier, W., Hulsken, J. and Behrens, J.: Adherens junction proteins in tumour progression. Cancer Surveys, 24: 129, 1995
56. Kawanishi, J., Kato, J., Sasaki, K., Fujii, S., Watanable, N. and Niitsu, Y.: Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol, 15: 1175, 1995
57. Nollet, F., Van Den Berg, A., Kersemaekers, A-M., Cleton-Jansen, A-M., Berx, G., Van Der Veen, A. Y., Eichperger, C., Wieland, I., De Greve, J., Liefers, G-J., Xiao, W-H., Buys C. H. C. M., Cornelisse, C. and Van Roy, F.: Allelic imbalance at the β-catenin gene (CTNNB1 at 3p22-21.3) in various human tumor types. Int J Oncol, 11: 311, 1997
58. Behrens, J., Von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschyedl, R. and Birchmeier, W.: Functional interaction of β- catenin with the transcription factor LEF-1. Nature, 382: 638, 1996
59. Daniel, J. M. and Reynolds, A. B.: Tyrosine phosphorylation and cadherin/catenin function. BioEssays, 19: 883, 1997
60. Hoosein, N. M., Boyd, D. D., Hollas, W. J., Mazar, A., Henkin, J. and Chung, L. W. K.: Involvement of urokinase and its receptor in the invasiveness of human prostatic-carcinoma cell-lines. Cancer Commun, 3: 255, 1991
61. + channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol, 150: 1213, 1997
62. Dahiya, R., Park, H. D., Cusick, J., Vessella, R. L., Fournier, G. and Narayan, P.: Inhibition of tumourigenic potential and prostate-specific antigen expression in LNCap human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer, 59: 126, 1994
63. Keer, H. N., Gaylis, F. D., Kozlowski, J. M., Kwaan, H. C., Bauer, K. D., Sinha, A. A. and Wilson, M. J.: Heterogeneity in plasminogen-activator (PA) levels in human prostate-cancer cell-lines - increased PA activity correlates with biologically aggressive behavior. Prostate, 18: 201, 1991